Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...

New research suggests that weight-loss drugs such as Ozempic and Wegovy may help some patients avoid knee replacement surgery.Earlier studies had shown that GLP-1 medications ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may slow some molecular signs linked to biological aging, according ...

Latest clinical data and research illustrate Regeneron’s advancement of innovative science for diverse and serious diseases with significant unmet needs ...

Glucagon-like peptide-1 receptor agonists, often called GLP-1 drugs, have become some of the most talked-about medicines in ...

Taxpayers are footing the bill for prisoners to access weight-loss drugs Ozempic and Mounjaro behind bars while regular ...

As real-world studies show high rates of GLP-1 discontinuation and rapid weight regain, new interventions may help patients ...

More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, ...

New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide ...

As Wegovy becomes available in the Emirates, Novo Nordisk senior executive urges doctors and patients to follow guidance ...

Adults taking semaglutide reported higher quality of life, including less pain and improved mobility. Learn how GLP-1 drugs could make life feel more manageable. Taking Ozempic (semaglutide) helped ...

Using Ozempic for weight loss without diabetes carries serious medical risks. Learn what experts say about its real impact on ...